SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-212644
Filing Date
2014-05-27
Accepted
2014-05-27 13:42:51
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d713998d10q.htm 10-Q 598391
2 EX-31.1 d713998dex311.htm EX-31.1 7651
3 EX-31.2 d713998dex312.htm EX-31.2 7686
4 EX-32.1 d713998dex321.htm EX-32.1 2812
5 EX-32.2 d713998dex322.htm EX-32.2 2858
  Complete submission text file 0001193125-14-212644.txt   3033703

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ceru-20140331.xml EX-101.INS 325344
7 XBRL TAXONOMY EXTENSION SCHEMA ceru-20140331.xsd EX-101.SCH 28650
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ceru-20140331_cal.xml EX-101.CAL 46314
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ceru-20140331_def.xml EX-101.DEF 105995
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ceru-20140331_lab.xml EX-101.LAB 271783
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ceru-20140331_pre.xml EX-101.PRE 184694
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 14869391
SIC: 2834 Pharmaceutical Preparations